Gene · 442918
Papers2,004
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,004
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of microRNA in Overactive Bladder: Relationship and Clinical Correlation. | Medicina (Kaunas) | 2025 | 40142286 | PubTator, text mining | PubMed |
| Multiple regulatory mechanisms, functions and therapeutic potential of chaperone-mediated autophagy. | Theranostics | 2025 | 40083922 | PubTator, text mining | PubMed |
| Diagnostic performance of microRNAs for predicting response to transarterial chemoembolization in hepatocellular carcinoma: a meta-analysis. | Front Oncol | 2024 | 39876897 | PubTator, text mining | PubMed |
| MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products-A Prospective Analysis. | Int J Mol Sci | 2024 | 39684593 | PubTator, text mining | PubMed |
| Screening of CAD-related secretory genes associated with type II diabetes based on comprehensive bioinformatics analysis and machine learning. | BMC Cardiovasc Disord | 2024 | 39501130 | PubTator, text mining | PubMed |
| Deciphering the multifaceted role of microRNAs in hepatocellular carcinoma: Integrating literature review and bioinformatics analysis for therapeutic insights. | Heliyon | 2024 | 39498055 | PubTator, text mining | PubMed |
| ZIP4: a promising early diagnostic and therapeutic targets for pancreatic cancer. | Am J Cancer Res | 2024 | 39417191 | PubTator, text mining | PubMed |
| [Retracted] LncRNA HOTAIR controls the expression of Rab22a by sponging miR‑373 in ovarian cancer. | Mol Med Rep | 2024 | 39364749 | PubTator, text mining | PubMed |
| Circulating miRNA-373 and Vascular Endothelial Growth Factor as Potential Biomarkers for Early Detection of Breast Cancer. | Indian J Clin Biochem | 2024 | 39346711 | PubTator, text mining | PubMed |
| Retraction: MicroRNA-373 Promotes Growth and Cellular Invasion in Osteosarcoma Cells by Activation of the PI3K/AKT-Rac1-JNK Pathway: The Potential Role in Spinal Osteosarcoma. | Oncol Res | 2024 | 39220129 | PubTator, text mining | PubMed |
| A DNA walker based on hairpin-shaped DNA aligner and fueled by nicking endonuclease for sensitive and rapid miRNA analysis. | Anal Chim Acta | 2024 | 38969432 | PubTator, text mining | PubMed |
| MoS2/MXene Van der Waals heterojunction-based electrochemiluminescence sensor for triple negative breast cancer detection. | Talanta | 2024 | 38823325 | PubTator, text mining | PubMed |
| Identification of miR-20a as A Potential Discerning Biomarker for Non-Invasive versus Invasive Retinoblastoma. | Cell J | 2024 | 38736409 | PubTator, text mining | PubMed |
| MicroRNA‑373‑3p inhibits the proliferation and invasion of non‑small‑cell lung cancer cells by targeting the GAB2/PI3K/AKT pathway. | Oncol Lett | 2024 | 38586211 | PubTator, text mining | PubMed |
| Targeting MicroRNAs with Small Molecules. | Noncoding RNA | 2024 | 38525736 | PubTator, text mining | PubMed |
| Identification of microRNA-mRNA Regulatory Networks with Therapeutic Values in Alzheimer's Disease by Bioinformatics Analysis. | J Alzheimers Dis | 2024 | 38427479 | PubTator, text mining | PubMed |
| Clinical importance of serum miRNA levels in breast cancer patients. | Discov Oncol | 2024 | 38280134 | PubTator, text mining | PubMed |
| Exosomal microRNA-92b Is a Diagnostic Biomarker in Breast Cancer and Targets Survival-Related MTSS1L to Promote Tumorigenesis. | Int J Mol Sci | 2024 | 38279296 | PubTator, text mining | PubMed |
| Distinctive Expression of MetastamiRs in Breast Cancer Mesenchymal Stem Cells Isolated from Solid Tumor. | Curr Stem Cell Res Ther | 2024 | 38265389 | PubTator, text mining | PubMed |
| Regulatory Non-Coding RNAs during Porcine Viral Infections: Potential Targets for Antiviral Therapy. | Viruses | 2024 | 38257818 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442918/papers?page=2